feed,title,long_url,short_url
Benzinga,Provention Bio Stock Craters After FDA Flags Deficiencies In PK Profiles From Teplizumab Trials For Diabetes,https://benzinga.com/general/biotech/21/04/20552835/provention-bio-stock-craters-after-fda-flags-deficiencies-in-pk-profiles-from-teplizumab-trials-f,https://j.mp/322QEtT
